Login

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$363.7K
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
7.37%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
-$2.963M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $38.13 Million

About Mountain Crest Acquisition Corp V

Mountain Crest Acquisition Corp V (MCAG) is a blank-check special purpose acquisition company (SPAC) organized to identify and complete a merger or business combination with a private operating company. It generates no operating revenue. Instead, it holds capital raised in its IPO in a trust account, with the intent to deploy that capital through a qualifying business combination. As of the 10-K filed March 16, 2026, MCAG had entered into a Business Combination Agreement dated August 29, 2024, with CUBEBIO Co., Ltd., a Korean corporation, under which MCAG would merge into a Cayman Islands holding company (CubeBio Holdings Limited, or PubCo), with CUBEBIO shareholders exchanging their shares for PubCo ordinary shares. If the combination closes, PubCo ordinary shares are expected to list on Nasdaq. MCAG trades on the OTC Pink Market. The company was founded and is led by Dr. Suying Liu, who serves as Chairman, Chief Executive Officer, and Chief Financial Officer, and who previously co-founded Mountain Crest Acquisition Corp (MCAC) in November 2019.

Revenue model
MCAG has no operating revenue. Capital from its IPO is held in a trust account and earns interest. Funds are returned to public shareholders via redemption if a business combination is not completed.
Products and services
Blank-check SPAC vehicle targeting a business combination. Pending transaction: merger with CUBEBIO Co., Ltd. (Korea) via a Cayman Islands holding company structure (CubeBio Holdings Limited).
Customers and end markets
Public shareholders who participate in the SPAC IPO and trust structure. No commercial customers or end markets, as MCAG is a pre-combination shell company.
Value-chain role
SPAC sponsor and acquisition vehicle. Raises capital from public markets and deploys it through a single business combination transaction.
Geographic exposure
Incorporated in the United States (Delaware). Pending combination involves CUBEBIO Co., Ltd., organized under Korean law. Post-combination holding company to be incorporated in the Cayman Islands.

Source: SEC 10-K, filed 2026-03-16

Industry: Surgical & Medical Instruments & Apparatus

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support